Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 9(12): e115428, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25522251

RESUMO

Phospholipases A2 represent the most abundant family of snake venom proteins. They manifest an array of biological activities, which is constantly expanding. We have recently shown that a protein bitanarin, isolated from the venom of the puff adder Bitis arietans and possessing high phospholipolytic activity, interacts with different types of nicotinic acetylcholine receptors and with the acetylcholine-binding protein. To check if this property is characteristic to all venom phospholipases A2, we have studied the capability of these enzymes from other snakes to block the responses of Lymnaea stagnalis neurons to acetylcholine or cytisine and to inhibit α-bungarotoxin binding to nicotinic acetylcholine receptors and acetylcholine-binding proteins. Here we present the evidence that phospholipases A2 from venoms of vipers Vipera ursinii and V. nikolskii, cobra Naja kaouthia, and krait Bungarus fasciatus from different snake families suppress the acetylcholine- or cytisine-elicited currents in L. stagnalis neurons and compete with α-bungarotoxin for binding to muscle- and neuronal α7-types of nicotinic acetylcholine receptor, as well as to acetylcholine-binding proteins. As the phospholipase A2 content in venoms is quite high, under some conditions the activity found may contribute to the deleterious venom effects. The results obtained suggest that the ability to interact with nicotinic acetylcholine receptors may be a general property of snake venom phospholipases A2, which add a new target to the numerous activities of these enzymes.


Assuntos
Neurônios/efeitos dos fármacos , Antagonistas Nicotínicos/farmacologia , Fosfolipases A2/farmacologia , Venenos de Serpentes/farmacologia , Potenciais de Ação , Sequência de Aminoácidos , Animais , Lymnaea , Dados de Sequência Molecular , Neurônios/fisiologia , Antagonistas Nicotínicos/química , Ligação Proteica , Receptores Nicotínicos/química , Receptores Nicotínicos/metabolismo , Venenos de Serpentes/química
2.
J Biol Chem ; 287(9): 6725-34, 2012 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-22223648

RESUMO

In Naja kaouthia cobra venom, we have earlier discovered a covalent dimeric form of α-cobratoxin (αCT-αCT) with two intermolecular disulfides, but we could not determine their positions. Here, we report the αCT-αCT crystal structure at 1.94 Å where intermolecular disulfides are identified between Cys(3) in one protomer and Cys(20) of the second, and vice versa. All remaining intramolecular disulfides, including the additional bridge between Cys(26) and Cys(30) in the central loops II, have the same positions as in monomeric α-cobratoxin. The three-finger fold is essentially preserved in each protomer, but the arrangement of the αCT-αCT dimer differs from those of noncovalent crystallographic dimers of three-finger toxins (TFT) or from the κ-bungarotoxin solution structure. Selective reduction of Cys(26)-Cys(30) in one protomer does not affect the activity against the α7 nicotinic acetylcholine receptor (nAChR), whereas its reduction in both protomers almost prevents α7 nAChR recognition. On the contrary, reduction of one or both Cys(26)-Cys(30) disulfides in αCT-αCT considerably potentiates inhibition of the α3ß2 nAChR by the toxin. The heteromeric dimer of α-cobratoxin and cytotoxin has an activity similar to that of αCT-αCT against the α7 nAChR and is more active against α3ß2 nAChRs. Our results demonstrate that at least one Cys(26)-Cys(30) disulfide in covalent TFT dimers, similar to the monomeric TFTs, is essential for their recognition by α7 nAChR, although it is less important for interaction of covalent TFT dimers with the α3ß2 nAChR.


Assuntos
Proteínas Neurotóxicas de Elapídeos/química , Dissulfetos/química , Receptores Nicotínicos/química , Alquilação , Sítios de Ligação , Proteínas Neurotóxicas de Elapídeos/metabolismo , Cristalografia por Raios X , Dimerização , Dissulfetos/metabolismo , Modelos Químicos , Ligação Proteica , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , Ensaio Radioligante , Receptores Nicotínicos/metabolismo , Receptor Nicotínico de Acetilcolina alfa7
3.
J Biol Chem ; 286(12): 10618-27, 2011 Mar 25.
Artigo em Inglês | MEDLINE | ID: mdl-21252236

RESUMO

Discovery of proteins expressed in the central nervous system sharing the three-finger structure with snake α-neurotoxins provoked much interest to their role in brain functions. Prototoxin LYNX1, having homology both to Ly6 proteins and three-finger neurotoxins, is the first identified member of this family membrane-tethered by a GPI anchor, which considerably complicates in vitro studies. We report for the first time the NMR spatial structure for the water-soluble domain of human LYNX1 lacking a GPI anchor (ws-LYNX1) and its concentration-dependent activity on nicotinic acetylcholine receptors (nAChRs). At 5-30 µM, ws-LYNX1 competed with (125)I-α-bungarotoxin for binding to the acetylcholine-binding proteins (AChBPs) and to Torpedo nAChR. Exposure of Xenopus oocytes expressing α7 nAChRs to 1 µM ws-LYNX1 enhanced the response to acetylcholine, but no effect was detected on α4ß2 and α3ß2 nAChRs. Increasing ws-LYNX1 concentration to 10 µM caused a modest inhibition of these three nAChR subtypes. A common feature for ws-LYNX1 and LYNX1 is a decrease of nAChR sensitivity to high concentrations of acetylcholine. NMR and functional analysis both demonstrate that ws-LYNX1 is an appropriate model to shed light on the mechanism of LYNX1 action. Computer modeling, based on ws-LYNX1 NMR structure and AChBP x-ray structure, revealed a possible mode of ws-LYNX1 binding.


Assuntos
Proteínas Ligadas por GPI/química , Modelos Moleculares , Receptores Nicotínicos/química , Proteínas Adaptadoras de Transdução de Sinal , Animais , Bungarotoxinas/química , Bungarotoxinas/farmacologia , Proteínas Ligadas por GPI/genética , Proteínas Ligadas por GPI/metabolismo , Humanos , Ressonância Magnética Nuclear Biomolecular , Oócitos , Ligação Proteica , Estrutura Quaternária de Proteína , Estrutura Terciária de Proteína , Receptores Nicotínicos/genética , Receptores Nicotínicos/metabolismo , Solubilidade , Xenopus laevis
4.
Toxicon ; 55(2-3): 186-94, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-19622365

RESUMO

Thrombin is a key enzyme in the blood coagulation cascade and is also involved in carcinogenesis; therefore, its inhibitors are of fundamental and clinical importance. Snake venoms are widely used as sources of proteins that affect blood coagulation. We have isolated a new protein, called TI-Nh, from the Naja haje cobra venom. TI-Nh is a mixed-type inhibitor of thrombin (K(i) of 72.8 nM for a synthetic peptide substrate) and effectively inhibits thrombin-induced platelet aggregation with an IC(50) value of 0.2 nM. At concentrations up to approximately 50 nM, at which the thrombin-clotting time is substantially prolonged, TI-Nh exerts no detectable effects on both the intrinsic and extrinsic pathways of the coagulation cascade. It does not hydrolyze either fibrinogen or thrombin. Although TI-Nh bears structural features typical of group IB phospholipases A(2) (PLA(2)s), it possesses relatively weak enzymatic activity and is nontoxic to PC12 cells at concentrations up to 15 microM. Nevertheless, TI-Nh evokes neurite outgrowth in these cells at a concentration of approximately 1 microM, similar to cytotoxic snake PLA(2)s with strong enzymatic activity. TI-Nh is the first thrombin inhibitor found in the venom of the Elapidae snake family, and it is the first phospholipase shown to inhibit thrombin.


Assuntos
Venenos Elapídicos/enzimologia , Venenos Elapídicos/farmacologia , Fosfolipases A2/farmacologia , Trombina/antagonistas & inibidores , Sequência de Aminoácidos , Animais , Coagulação Sanguínea/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Proteínas do Sistema Complemento/efeitos dos fármacos , Dessecação , Egito , Venenos Elapídicos/química , Fator VIIa/antagonistas & inibidores , Fibrina/química , Humanos , Técnicas In Vitro , Dados de Sequência Molecular , Peso Molecular , Neuritos/efeitos dos fármacos , Agregação Plaquetária/efeitos dos fármacos , Proteínas/química , Inibidores de Serina Proteinase/farmacologia , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Tromboplastina/antagonistas & inibidores , Inibidores da Tripsina/farmacologia , Tempo de Coagulação do Sangue Total
5.
Toxicon ; 53(1): 162-8, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19041663

RESUMO

Cysteine-rich proteins found in animal venoms (CRISP-Vs) are members of a large family of cysteine-rich secretory proteins (CRISPs). CRISP-Vs acting on different ion channels were found in venoms or mRNA (cDNA) encoding CRISP-Vs were cloned from snakes of three main families (Elapidae, Colubridae and Viperidae). About thirty snake CRISP-Vs were sequenced so far, however no complete sequence for CRISP-V from Viperinae subfamily was reported. We have cloned and sequenced for the first time cDNAs encoding CRISP-Vs from Vipera nikolskii and Vipera berus vipers (Viperinae). The deduced mature CRISP-V amino acid sequences consist of 220 amino acid residues. Phylogenetic analysis showed that viper proteins are closely related to those of Crotalinae snakes. The presence of CRISP-V in the V. berus venom was revealed using a combination of gel-filtration chromatography, electrophoresis and MALDI mass spectrometry. The finding of the putative channel blocker in viper venom may indicate its action on prey nervous system.


Assuntos
Cisteína/química , Filogenia , Proteínas/química , Proteínas/genética , Venenos de Víboras/química , Viperidae/fisiologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Clonagem Molecular , DNA Complementar , Dados de Sequência Molecular , RNA/química , RNA/genética , Venenos de Víboras/genética , Venenos de Víboras/metabolismo , Viperidae/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA